Intech Biopharm (Taiwan) Market Value
| 6461 Stock | TWD 24.30 0.40 1.67% |
| Symbol | Intech |
Intech Biopharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Intech Biopharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Intech Biopharm.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Intech Biopharm on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Intech Biopharm or generate 0.0% return on investment in Intech Biopharm over 90 days. Intech Biopharm is related to or competes with Winstek Semiconductor, Hi Sharp, Sea Sonic, Sinopower Semiconductor, and Syntek Semiconductor. More
Intech Biopharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Intech Biopharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Intech Biopharm upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 9.46 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 3.24 |
Intech Biopharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intech Biopharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Intech Biopharm's standard deviation. In reality, there are many statistical measures that can use Intech Biopharm historical prices to predict the future Intech Biopharm's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | 0.0456 | |||
| Treynor Ratio | (17.58) |
Intech Biopharm Backtested Returns
Intech Biopharm holds Efficiency (Sharpe) Ratio of -0.1, which attests that the entity had a -0.1 % return per unit of risk over the last 3 months. Intech Biopharm exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Intech Biopharm's Risk Adjusted Performance of (0.08), market risk adjusted performance of (17.57), and Standard Deviation of 1.66 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.0092, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Intech Biopharm's returns are expected to increase less than the market. However, during the bear market, the loss of holding Intech Biopharm is expected to be smaller as well. At this point, Intech Biopharm has a negative expected return of -0.15%. Please make sure to check out Intech Biopharm's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Intech Biopharm performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.74 |
Good predictability
Intech Biopharm has good predictability. Overlapping area represents the amount of predictability between Intech Biopharm time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Intech Biopharm price movement. The serial correlation of 0.74 indicates that around 74.0% of current Intech Biopharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.81 |
Intech Biopharm lagged returns against current returns
Autocorrelation, which is Intech Biopharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Intech Biopharm's stock expected returns. We can calculate the autocorrelation of Intech Biopharm returns to help us make a trade decision. For example, suppose you find that Intech Biopharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Intech Biopharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Intech Biopharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Intech Biopharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Intech Biopharm stock over time.
Current vs Lagged Prices |
| Timeline |
Intech Biopharm Lagged Returns
When evaluating Intech Biopharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Intech Biopharm stock have on its future price. Intech Biopharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Intech Biopharm autocorrelation shows the relationship between Intech Biopharm stock current value and its past values and can show if there is a momentum factor associated with investing in Intech Biopharm.
Regressed Prices |
| Timeline |
Pair Trading with Intech Biopharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intech Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intech Biopharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Intech Stock
Moving against Intech Stock
| 0.7 | 2887F | Taishin Financial Holding | PairCorr |
| 0.62 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.59 | 2887E | Taishin Financial Holding | PairCorr |
| 0.39 | 2412 | Chunghwa Telecom | PairCorr |
| 0.38 | 4147 | TaiMed Biologics | PairCorr |
The ability to find closely correlated positions to Intech Biopharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intech Biopharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intech Biopharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intech Biopharm to buy it.
The correlation of Intech Biopharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intech Biopharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intech Biopharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intech Biopharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.